Chairs

Geoffrey M. Levitt

Senior Vice President and Associate General Counsel Regulatory
Pfizer Inc.

Co-Chairs’ Opening Remarks

March 23, 2017 9:00 am

Seth A. Mailhot

Partner
Michael Best & Friedrich LLP (Washington, DC)

Speakers

James Beck

Partner
Reed Smith LLP (Philadelphia, PA)

Maya P. Florence

Counsel
Skadden, Arps, Slate, Meagher & Flom LLP (Boston, MA)

Kurt Karst

Director
Hyman, Phelps & McNamara, P.C.

Part 2: Hatch-Waxman and BPCIA Overview

March 23, 2017 4:00 pm

Geoffrey M. Levitt

Senior Vice President and Associate General Counsel Regulatory
Pfizer Inc.

Co-Chairs’ Opening Remarks

March 23, 2017 9:00 am

Jill K. MacAlpine

Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Seth A. Mailhot

Partner
Michael Best & Friedrich LLP (Washington, DC)

Christina M. Markus

Partner and Deputy Chair of FDA & Life Sciences Group
King & Spalding

Donna M. Meuth

Associate General Counsel, Intellectual Property
Eisai Inc.

Alan G. Minsk

Partner, Head of Food and Drug Team
Arnall Golden Gregory LLP

Drugs and Biologics: Labeling

March 23, 2017 2:15 pm

Donald Ware

Partner and Chair of Intellectual Property Department
Foley Hoag LLP

Part 2: Hatch-Waxman and BPCIA Overview

March 23, 2017 4:00 pm

Natalie F. Zaidman

Senior Corporate Counsel
Pfizer Inc